IBM shares fell more than 3% Wednesday even as the Nasdaq, S&P 500 and technology stocks advanced. Benzinga Pro cited possible profit-taking after IBM’s stock had rallied about 40% since late July, while traders awaited the Federal Reserve’s rate decision and commentary. IBM’s Anderon unit finalized a $1 billion CHIPS and Science Act award with the U.S. Department of Commerce for research and development at its 300-millimeter quantum wafer foundry in Albany, New York; IBM is investing another $1 billion in the venture. The stock remained above its 20-day and 50-day simple moving averages but below its 100-day and 200-day averages, with neutral RSI momentum and mixed technical signals. Analysts have a consensus Buy rating and an average price forecast of $258, while Benzinga Edge rankings showed strong quality but weak momentum and value. IBM is also a major holding in several dividend-focused technology ETFs, whose flows can affect trading in the shares.